HESTER BIOSCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,400 INR | -2.61% |
|
+15.50% | +64.65% |
| 05-10 | Transcript : Hester Biosciences Limited, Q4 2024 Earnings Call, May 10, 2024 | |
| 05-10 | Hester Biosciences' Consolidated Net Profit Rises in Fiscal Q4; Shares Jump 4% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Veterinary Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 80.52B | ||||||
| 7.05B | - | |||||
| 3.56B | ||||||
| 3B | ||||||
| 1.71B |
